1. Home
  2. MGYR vs FATE Comparison

MGYR vs FATE Comparison

Compare MGYR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$17.20

Market Cap

112.7M

Sector

Finance

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
FATE
Founded
1922
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.7M
125.6M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
MGYR
FATE
Price
$17.20
$2.10
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
3.6K
4.1M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
29.88
EPS
0.98
N/A
Revenue
N/A
$6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.00
$0.91
52 Week High
$20.00
$2.88

Technical Indicators

Market Signals
Indicator
MGYR
FATE
Relative Strength Index (RSI) 65.58 51.87
Support Level $16.96 $1.01
Resistance Level $18.88 $2.88
Average True Range (ATR) 0.17 0.21
MACD 0.08 -0.04
Stochastic Oscillator 100.00 28.12

Price Performance

Historical Comparison
MGYR
FATE

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: